2,5-Di-t-butyl-1,4-benzohydroquinone induces endothelium-dependent relaxation of rat thoracic aorta

Eur J Pharmacol. 1999 Feb 5;366(2-3):181-7. doi: 10.1016/s0014-2999(98)00932-7.

Abstract

The aim of this work was to clarify the mechanism by which 2,5-di-t-butyl-1,4-benzohydroquinone (BHQ) induces relaxation of rat thoracic aorta. In particular, the role of endothelium-derived nitric oxide (NO) was investigated. BHQ concentration dependently (0.1-10 microM) relaxed rat aorta rings precontracted with phenylephrine. This effect was dependent on the intactness of the endothelium, suppressed by preincubation with 100 microM N(omega)-nitro-L-arginine methyl ester and antagonised by 3-30 microM methylene blue. The 10 microM BHQ-induced relaxation, however, was followed by the gradual and slow return to phenylephrine-induced tone. Superoxide dismutase (250 U/ml) increased the BHQ-induced relaxation, while preincubation with 3 mM diethyldithiocarbamate inhibited it in a time-dependent fashion. BHQ gave rise to superoxide anion formation which was markedly inhibited by the addition of superoxide dismutase (250 U/ml), either in the presence or in the absence of aorta rings. The non-specific blocker of Ca2+ channels, Ni2+, concentration dependently attenuated the BHQ relaxing effect. BHQ did not modify the relaxation induced by the NO donor 3-morpholino-sydnonimine in endothelium-deprived rings. In conclusion, BHQ induces endothelium-dependent relaxation and gives rise, by auto-oxidation, to the formation of superoxide anion. The former effect results from the enhanced synthesis of NO rather than from its enhanced biological activity; NO synthase is presumed to be stimulated by BHQ-induced activation of Ca2+ influx through Ni2+-sensitive Ca2+ channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta, Thoracic / drug effects*
  • Aorta, Thoracic / physiology
  • Chelating Agents / pharmacology
  • Ditiocarb / pharmacology
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / physiology*
  • Enzyme Inhibitors / pharmacology*
  • Free Radical Scavengers / pharmacology
  • Hydroquinones / pharmacology*
  • In Vitro Techniques
  • Male
  • Molsidomine / analogs & derivatives
  • Molsidomine / pharmacology
  • Muscle Relaxation / drug effects*
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nickel / pharmacology
  • Phenylephrine / pharmacology
  • Rats
  • Rats, Wistar
  • Superoxide Dismutase / pharmacology
  • Superoxides / metabolism
  • Vasoconstrictor Agents / pharmacology

Substances

  • Chelating Agents
  • Enzyme Inhibitors
  • Free Radical Scavengers
  • Hydroquinones
  • Vasoconstrictor Agents
  • Superoxides
  • Phenylephrine
  • 2,5-di-tert-butylhydroquinone
  • linsidomine
  • Nickel
  • Ditiocarb
  • Molsidomine
  • Superoxide Dismutase
  • NG-Nitroarginine Methyl Ester